OVIDOvid Therapeutics Inc.
What is the market doing?
No clear lean: rangebound and heavily shorted.
Rangebound, no clear trend. Price is −9% vs its 200-day average.
Heavily shorted, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How OVID is trading
Ovid Therapeutics Inc. is +33% over the past year while the S&P 500 is +16%: 17 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −8.5%
vs 200-day average · below trend, but not far
- RSI (14)
- 42
RSI (14) · neutral
- Below its 52-week high
- 28%
Below its 52-week high
Details›
- Last close2026-10-23
- $2.15
- 1 monthS&P 500 −0.94%
- −14%
- 1 yearS&P 500 +16%
- +33%
- 5 yearsS&P 500 +86%
- −40%
- vs 50-day average$2.59
- −17%
- 52-week high
- $2.96
- 52-week low
- $1.20
- Annualised volatility
- 95%
| Year | Return |
|---|---|
| 2026 (year to date) | +32% |
| 2025 | +75% |
| 2024 | −71% |
| 2023 | +73% |
| 2022 | −42% |
| 2021 | +39% |
| 2020 | −44% |
| 2019 | +71% |
| 2018 | −75% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 9 | 4 of 9 | +2.1% |
| Feb | 9 | 3 of 9 | −6.6% |
| Mar | 9 | 4 of 9 | +0.24% |
| Apr | 9 | 6 of 9 | +13% |
| May | 9 | 3 of 9 | −4.0% |
| Jun | 10 | 4 of 10 | −0.64% |
| Jul | 10 | 5 of 10 | +7.3% |
| Aug | 10 | 4 of 10 | +13% |
| Sep | 10 | 4 of 10 | +5.9% |
| Oct | 10 | 2 of 10 | −10% |
| Nov | 9 | 6 of 9 | +23% |
| Dec | 9 | 2 of 9 | −16% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.